Loading data
RNAZNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 13.42 m USD | 9.71 m USD | 12.26 m USD | 10.23 m USD | 2.75 m USD |
| Operating profit | -27.98 m USD | -15.66 m USD | -19.42 m USD | -18.63 m USD | -6.15 m USD |
| Interest expense | — | 26.81 k USD | 55.9 k USD | 31.99 k USD | 95.07 k USD |
| Profit before tax | -34.44 m USD | -16.75 m USD | — | — | — |
| Income tax expense | 226.07 k USD | 0 USD | 0 USD | 0 USD | 53.05 k USD |
| Net income (reported basis) | -34.66 m USD | -16.75 m USD | -18.55 m USD | -17.56 m USD | -6.84 m USD |
| Net income attributable to common shareholders | -36.27 m USD | -16.79 m USD | -18.55 m USD | — | — |
| Basic earnings per share | -52.59 USD/share | -1,336.63 USD/share | -3,419.01 USD/share | -1,082.79 USD/share | -0.81 USD/share |
| Diluted earnings per share | -52.59 USD/share | -1,336.63 USD/share | -3,419.01 USD/share | -1,082.79 USD/share | -0.81 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.